drugset / Trial / NCT01011426

Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients

NCT01011426

Phase 2 Completed 285 enrolled The Cooper Health System
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether Bisacodyl, 5 mg usage decreases the incidence of nausea and abdominal pain after surgery, and also decreases the number of hospitalization days.

Timeline

Start
2009-04
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisacodyl Small molecule 5 mg Oral

Indications

No indication recorded.